Merck prides itself on innovation in all areas of drug research and development with programs focused on satisfying unmet medical needs. Our dedication to basic research is a critical component of our mission and overall philosophy. We are committed to augmenting our internal research capabilities with strong external alliances, ranging from targeted acquisitions to research collaborations, licensing preclinical compounds and clinical compounds and technology transactions. These external collaborations are a fundamental and ongoing component of our research and development strategy.

The content on this page was last modified on September 15, 2009.

Merck & Co., Inc., Whitehouse Station, NJ, USA, and Schering-Plough Corporation, Kenilworth, NJ, USA, are now one company. We have combined our global operations under the name Merck & Co., Inc. We are working to update our corporate responsibility Web site to reflect our new, combined, global organization.